DeepMed Research

Shanghai Fudan University Huashan Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The TMS Treatment for Postoperative Headache in GH Tumor

Not Applicable

Conditions: Headache
Pituitary Tumor
Acromegaly

Interventions: Device: Transcranial magnetic stimulation
Drug: Acetaminophen

First Posted Date: 2020-08-27

Last Posted Date: 2020-08-27

Lead Sponsor: Huashan Hospital

Target Recruit Count: 200

Registration Number: NCT04529356

Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis

Phase 3

Conditions: Infertility, Female
Recurrent Implantation Failure
Genital Tuberculoses, Female
Genital Tuberculosis, Latent

Interventions: Drug: rifapentine plus isoniazid

First Posted Date: 2020-08-27

Last Posted Date: 2020-08-27

Lead Sponsor: Huashan Hospital

Target Recruit Count: 1050

Registration Number: NCT04528277

Locations: 🇨🇳
Shanghai First Maternity and Infant Hospital, Shanghai, Shanghai, China

A Pilot Study of Empagliflozin in the Treatment of Acromegalic Cardiomyopathy

Not Applicable

Conditions: Acromegaly
Cardiomyopathies

Interventions: Drug: Empagliflozin

First Posted Date: 2020-08-20

Last Posted Date: 2020-08-20

Lead Sponsor: Huashan Hospital

Target Recruit Count: 10

Registration Number: NCT04520646

Locations: 🇨🇳
Huashan Hospital, Shanghai, Shanghai, China

Screening for Atrial Fibrillation With Prolonged Continuous Single-lead ECG Devices in High-risk Patients

Conditions: Atrial Fibrillation

First Posted Date: 2020-08-19

Last Posted Date: 2020-08-19

Lead Sponsor: Huashan Hospital

Target Recruit Count: 300

Registration Number: NCT04519190

CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke -Tenecteplase II

Phase 2

Completed

Conditions: Stroke

Interventions: Drug: The best treatment selected by local doctors(Aspirin, Recombinant Tissue Plasminogen Activator, Urokinase, Thrombectomy)
Drug: Tenecteplase

First Posted Date: 2020-08-18

Last Posted Date: 2023-11-29

Lead Sponsor: Huashan Hospital

Target Recruit Count: 224

Registration Number: NCT04516993

Locations: 🇨🇳
Huashan Hospital, Shanghai, Shanghai, China

Postoperative Thrombosis Prevention in Patients With CD

Not Applicable

Conditions: Pulmonary Embolism
Cushing Disease
DVT

Interventions: Device: IPC
Drug: LMWH/Rivaroxaban

First Posted Date: 2020-07-27

Last Posted Date: 2022-07-12

Lead Sponsor: Huashan Hospital

Target Recruit Count: 206

Registration Number: NCT04486859

Locations: 🇨🇳
The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
🇨🇳
China West Hospital, Chengdu, Sichuan, China
🇨🇳
People's Hopital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China

and more 4 locations

MDR-TB Close Contacts Tracing in China (TCCT Study)

Conditions: Multidrug Resistant Tuberculosis

First Posted Date: 2020-07-23

Last Posted Date: 2020-07-23

Lead Sponsor: Huashan Hospital

Target Recruit Count: 500

Registration Number: NCT04484129

Locations: 🇨🇳
Huashan Hospital of Fudan University, Shanghai, Shanghai, China
🇨🇳
The Central Hospital of Wenzhou City, Wenzhou, Zhejiang, China
🇨🇳
Guiyang Public Health Treatment Center, Guizhou, Guizhou, China

and more 5 locations

Delayed Diagnosis of Bacteriologically Positive Pulmonary Tuberculosis and Relative Optimized Suggestions in China

Completed

Conditions: Tuberculosis; Pulmonary, Confirmed, Unspecified Means

First Posted Date: 2020-06-17

Last Posted Date: 2020-06-17

Lead Sponsor: Huashan Hospital

Target Recruit Count: 400

Registration Number: NCT04434976

Locations: 🇨🇳
The 2th Hospital of Daqing, Daqing, Hei Longjiang, China
🇨🇳
Wuhan Medical Treatment Center, Wuhan, Hubei, China
🇨🇳
Jiangxi Province Chest Hospital, Nanchang, Jiangxi, China

and more 17 locations

Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study

Early Phase 1

Recruiting

Conditions: Myasthenia Gravis, Generalized

Interventions: Drug: Tofacitinib 5 MG

First Posted Date: 2020-06-16

Last Posted Date: 2022-09-02

Lead Sponsor: Huashan Hospital

Target Recruit Count: 20

Registration Number: NCT04431895

Locations: 🇨🇳
Huashan Hospital, Shanghai, China

Influencing Factors of Cerebrovascular Disease and Cognition in Hemodialysis Patients

Recruiting

Conditions: Cognitive Impairment
Cerebrovascular Disorders
Hemodialysis

First Posted Date: 2020-06-16

Last Posted Date: 2024-02-28

Lead Sponsor: Huashan Hospital

Target Recruit Count: 20

Registration Number: NCT04433455

Locations: 🇨🇳
Huashan Hospital, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy